N-(2-Bromo-5-nitrophenyl)-N-ethylacetamide

ID: ALA4449216

PubChem CID: 155520761

Max Phase: Preclinical

Molecular Formula: C10H11BrN2O3

Molecular Weight: 287.11

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCN(C(C)=O)c1cc([N+](=O)[O-])ccc1Br

Standard InChI:  InChI=1S/C10H11BrN2O3/c1-3-12(7(2)14)10-6-8(13(15)16)4-5-9(10)11/h4-6H,3H2,1-2H3

Standard InChI Key:  LZFLNCLYKIPQCW-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 16 16  0  0  0  0  0  0  0  0999 V2000
   21.2951   -3.7475    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.2939   -4.5670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0020   -4.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7116   -4.5665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7088   -3.7439    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.0002   -3.3386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5873   -3.3391    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   20.5871   -2.5219    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.8797   -3.7478    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4150   -3.3326    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   23.4119   -2.5154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.1181   -2.1042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.7027   -2.1095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.4200   -4.9740    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   24.1242   -3.7386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.8304   -3.3273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  1  7  1  0
  7  8  1  0
  7  9  2  0
  5 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
  4 14  1  0
 10 15  1  0
 15 16  1  0
M  CHG  2   7   1   8  -1
M  END

Alternative Forms

  1. Parent:

    ALA4449216

    ---

Associated Targets(Human)

PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hep 3B2 (2332 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HUVEC (11049 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Putative nitroreductase (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 287.11Molecular Weight (Monoisotopic): 285.9953AlogP: 2.73#Rotatable Bonds: 3
Polar Surface Area: 63.45Molecular Species: NEUTRALHBA: 3HBD:
#RO5 Violations: HBA (Lipinski): 5HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.14CX LogD: 2.14
Aromatic Rings: 1Heavy Atoms: 16QED Weighted: 0.63Np Likeness Score: -1.73

References

1. Güngör T, Önder FC, Tokay E, Gülhan ÜG, Hacıoğlu N, Tok TT, Çelik A, Köçkar F, Ay M..  (2019)  PRODRUGS FOR NITROREDUCTASE BASED CANCER THERAPY- 2: Novel amide/Ntr combinations targeting PC3 cancer cells.,  171  [PMID:30928710] [10.1016/j.ejmech.2019.03.035]

Source